Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001079973-25-001248
Filing Date
2025-08-12
Accepted
2025-08-12 17:32:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5161
  Complete submission text file 0001079973-25-001248.txt   6716
Mailing Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD SUITE 150 SAN DIEGO CA 92121 858-369-7100
MEI Pharma, Inc. (Subject) CIK: 0001262104 (see all company filings)

EIN.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-79594 | Film No.: 251208160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address KAISER-FRIEDRICH-ALLEE 2 AACHEN 2M 52074
Business Address
Schornstein Alexander (Filed by) CIK: 0001999256 (see all company filings)